Abstract
Background
Hypermagnesemia is one of the vital electrolyte disturbances and is associated with such chronic conditions as cardiovascular, endocrinologic, renal diseases, and malignancy.
Aim
This study evaluates the association between hypermagnesemia and clinical course in hospitalized patients.
Methods
This study was conducted at the University of Health Sciences Haseki Training and Research Hospital Internal Medicine Clinic. We evaluated a total of 3850 patients. 2130 patients have met the inclusion criteria were included in the study. Those who were discharged with healing were evaluated as having a good prognosis. Patients who died or were transferred to the intensive care unit (ICU) were defined as having a poor prognosis. We divided the patients' serum magnesium levels into four quartiles and examined the clinical course/conditions of the patients.
Results
Of 2130 patients, 1013 (51.9%) were female. The mean age of patients with poor prognoses (69.2 ± 14.9) was higher than those with good prognoses (59.7 ± 19.1). Hypermagnesemia (4th quartile) was detected in 61 (33.9%), and hypomagnesemia (1st quartile) was found in 42 (23.3%) patients out of 180 patients with poor clinical outcomes. It was statistically significant that hypermagnesemia was more common in patients with poor prognoses (p: 0.002). Chronic kidney disease (CKD) was diagnosed in 258 (53.3%) of 484 hypermagnesemia patients. Hypermagnesemia was found to be more common in patients with CKD, which was statistically significant (p: 0.003).
Conclusions
Hypermagnesemia is associated with poor prognosis independent of comorbidities. Besides hypomagnesemia, hypermagnesemia should be considered a critical electrolyte imbalance.
This is a preview of subscription content, log in via an institution to check access.
Similar content being viewed by others
Data availability
All data supporting the findings of this study are available within the paper and its supplementary information.
References
Schwalfenbergand GK, Genuis SJ (2017) The importance of magnesium in clinical healthcare. Scientifica 5:4–10. https://doi.org/10.1155/2017/4179326
Cirik MÖ, Kilinç M, Doğanay GE et al (2020) The relationship between magnesium levels and mortality in the respiratory intensive care unit. Medicine (Baltimore) 99(52):e23290. https://doi.org/10.1097/MD.0000000000023290
Broman M, Hansson F, Klarin B (2018) Analysis of hypo- and hypermagnesemia in an intensive care unit cohort. Acta Anaesthesiol Scand 62(5):648–657. https://doi.org/10.1111/aas.13061
Swaminathan R (2003) Magnesium metabolism and its disorders. Clin Biochem Rev 24(2):47–66
Nadler JL, Rude RK (1995) Disorders of magnesium metabolism. Endocrinol Metab Clin North Am 24(3):623–641
Haider DG, Lindner G, Ahmad SS et al (2015) Hypermagnesemia is a strong independent risk factor for mortality in critically ill patients: Results from a cross-sectional study. Eur J Intern Med 26(7):504–507. https://doi.org/10.1016/j.ejim.2015.05.013
Stevens JS, Moses AA, Nickolas TL et al (2021) Increased mortality associated with hypermagnesemia in severe covid-19 illness. Kidney360 2(7):1087–1094. https://doi.org/10.34067/KID.0002592021
Azem R, Daou R, Bassil E et al (2020) Serum magnesium, mortality and disease progression in chronic kidney disease. BMC Nephrol 21:49. https://doi.org/10.1186/s12882-020-1713-3
Tan L, Xu Q, Li C et al (2021) High-normal serum magnesium and hypermagnesemia are associated with increased 30-day in-hospital mortality: a retrospective cohort study. Front Cardiovasc Med. 8:625133. https://doi.org/10.3389/fcvm.2021.625133
Angkananard T, Anothaisintawee T, Eursiriwan S et al (2016) The association of serum magnesium and mortality outcomes in heart failure patients: A systematic review and meta-analysis. Medicine 95(50):e5406. https://doi.org/10.1097/MD.0000000000005406
Pokharel DR, Khadka D, Sigdel M et al (2017) Association of serum magnesium level with poor glycemic control and renal functions in Nepalese patients with type 2 diabetes mellitus. Diabetes Metab Syndr 11:417–423. https://doi.org/10.1016/j.dsx.2017.03.028
D’Erasmo E, Celi FS, Acca M et al (1991) Hypocalcemia and hypomagnesemia in cancer patients. Biomed Pharmacother 45(7):315–317
Kieboom BC, Niemeijer MN, Leening MJ et al (2016) Serum magnesium and the risk of death from coronary heart disease and sudden cardiac death. J Am Heart Assoc 5(1):e002707. https://doi.org/10.1161/JAHA.115.002707
Massy ZA, Drüeke TB (2015) Magnesium and cardiovascular complications of chronic kidney disease. Nat Rev Nephrol 11(7):432–442. https://doi.org/10.1038/nrneph.2015.74. Epub 2015 May 12 PMID: 25963594
Thongprayoon C, Hansrivijit P, Petnak T et al (2022) Impact of serum magnesium levels at hospital discharge and one-year mortality. Postgrad Med 134(1):47–51. https://doi.org/10.1080/00325481.2021.1931369
Cheungpasitporn W, Thongprayoon C, Bathini T et al (2020) Impact of admission serum magnesium levels on long-term mortality in hospitalized patients. Hosp Pract (1995) 48(2):80–85. https://doi.org/10.1080/21548331.2020.1724723
Author information
Authors and Affiliations
Corresponding author
Ethics declarations
Conflicts of interest
The authors declare no conflict of interest.
Additional information
Publisher's Note
Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Hoca, E., Arat, E.K., Arat, O. et al. Hypermagnesemia is associated with poor outcomes during hospitalization. Ir J Med Sci 193, 733–739 (2024). https://doi.org/10.1007/s11845-023-03518-z
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s11845-023-03518-z